MyJournals Home  

RSS FeedsSTAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer (British Journal of Pharmacology)

 
 

1 april 2021 15:40:09

 
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer (British Journal of Pharmacology)
 


British Journal of Pharmacology, EarlyView.


 
196 viewsCategory: Pharmacology
 
[ASAP] The Uniqueness of Albumin as a Carrier in Nanodrug Delivery (Molecular Pharmaceutics)
[ASAP] Correction to “Bionano Interactions of MCF-7 Breast Tumor Cells with a Transferrin Receptor Targeted Nanoparticle” (Molecular Pharmaceutics)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten